- Price
Supplier Type
- Manufacturer
- Reagent
- Trader
- contract manufacturer
- custom synthesis
Supplier Region
- Gujarat(35)
- Maharashtra(34)
- Hyderabad(24)
- Tamil Nadu(3)
- Mumbai(60)
- Andhra Pradesh(3)
- Ahmedabad(16)
- Delhi(14)
- Beijing(3)
- Bangalore(3)
- New Delhi(5)
- Pune(6)
- Vadodara(8)
- Karnataka(5)
- Uttar Pradesh(8)
- Madhya Pradesh(1)
- Punjab(4)
- Haryana(5)
- Telangana(1)
- Nagpur(2)
- Rajasthan(1)
- Kolkata(1)
Purity
- Starch-15, Lactose-85
- Salicylic Acid
- Rasagiline Mesylate Impurity C
- NLT 95%
- NLT 90%
- more than 95%
- more than 90%
- MINIMUM 98%
- Min. 99%
- min 99.0%
- MIN 98%
- Mesalazine EP Impurity H
- Mathadone (M225865) impurity. Used in synthesis of methadone, antispasmodics and other pharmaceutica
- Greater than 99%
- Dipropargyl r- amino indane
- Dapagliflozin Intermediate, Dapagliflozin Impurity
- API Impurity / In-house working standard
- Acetylsalicylic Acid EP Impurity C
- ABOVE 99%
- 99.98%
- 99.96%
- 99.95%
- 99.91%
- 99.9%
- 99.86%
- 99.85%
- 99.80%
- 99.73%
- 99.5%
- ≥ 99.5%
- 99.42%
- 99.40%
- 99.29%
- 99.20%
- 99%
- >99%
- 99 % PURITY
- 99 %
- 98-100%
- 98+
- 98.81%
- 98.60%
- 98.12%
- 98.00%
- 98%
- >98%
- 98 %
- 97-99%
- 97.57%
- 97.00%
- >97%
- 97%
- 97 %
- 96.80%
- 96.39%
- 96.30%
- 96%
- 95-99%
- 95.00%
- 95%
- >95%
- 94.00%
- >92%
- 90.00%
- 90%
- >90%
- 90 % Above
- 48%
- 25 MG 50 MG 100 MG 250 MG EXTRA
- 15%/23%/33%
- 15%/20%/23%/30% & 1.6M
- 15%
- 15
- 12%/15%
- 10-15 %
- 100% Pure
- 100%
- 100 %
- (R)-N,N-di(prop-2-yn-1-yl)-2,3- dihydro-1
Package
- 0Customized pack size availaible
- 0MG TO GRAM
- 25mg
- 50mg
- 2.5501e+00925 MG 50 MG 100 MG 250 MG EXTRA
- 100mg
- 250mg
- 500mg
- 1000mg
- 1g
- 1gm
- 5g
- 10g
- 25gm
- 25g
- 50g
- 50gm
- 100ml
- 100gm
- 100g
- 200gm
- 250gm
- 500g
- 500gm
- 500ml
- 1L
- 1kg
- 5kg
- 10kg
- 25kg
- 50kg
- 100kg
- 500kg
- 1MT
- 1and gm
- 3MT
- 50 gms
- 95NLT %
- 100 gms
- 500gms
- 250250 mg.
-
4'-(azidomethyl)-[1,1'-biphenyl]-2-carboxylic acid
2758005-15-9
-
Oseltamivir Impurity 50
651324-06-0
-
Olaparib Impurity 15 (Z-Isomer)
2905341-99-1
-
Ibrutinib Impurity 27
2031255-26-0
-
1(3H)-Isobenzofuranone, 3-[[3-[[4-(cyclopropylcarbonyl)-1-piperazinyl]carbonyl]-4-fluorophenyl]methylene]-, (3E)-
2905341-98-0
-
alpha-[2-Fluoro-4-(1H-1,2,4-triazol-1-yl)phenyl]-alpha-(1H-1,2,4-triazol-1-ylmethyl)-1H-1,2,4-triazole-1-ethanol
871550-15-1
-
2-Methyl-4-hydroxy-2H-1,2-benzisothiazine-3-carboxylic acid ethyl ester-1,1-diox
35511-15-0
-
DESETHYL HYDROXY CHLOROQUINE
4298-15-1
-
5-Oxo Pitavastatin
222306-15-2
-
1,3-Propanediamine, N1,N1,N3-trimethyl-N3-[3-[[1-(phenylmethyl)-1H-indazol-3-yl]oxy]propyl]-
1337966-15-0
Carbon disulfide 75-15-0
Carvedilol EP Impurity B 918903-20-5
meso-Tetrakis(o-pyridyl)porphine; Tetra-(2-pyridyl)-porphin; 5,10,15,20-Tetra-2-pyridylporphine; meso-Tetrakis(2-pyridyl)porphine; 5,10,15,20-tetra(2-pyridyl)porphyrin; meso-Tetra-2-pyridylporphine; meso-Tetra-(2-pyridyl)-porphyrin; 5,10,15,20-tetrakis(2-pyridyl)porphyrin; meso-Tetrakis(2-pyridyl)porphyrin; 5,10,15,20-tetra-pyridin-2-yl-21H,23H-porphine 40904-90-3
RCMH 181289-15-6
Omega 3 Fatty Acid Capsule, Packaging Type: Blister, Packaging Size: 1*15
